- The “Normal Distribution” Concept
- Anatomy Of The National Drug Code
- Randomization—An Interview with Ken Traub—Part 1: GS1 Serial Number Considerations
- Just Released - The HDMA EDI ASN Guidance For DSCSA
- The Differences Between The DSCSA, FDA Rules and Guidance
- Is Your Drug Exempt From The Federal Drug Supply Chain Security Act?
- DSCSA: Transaction Statement
Posts Tagged ‘Supply Network Blog’
I recently read in Pharmaceutical Commerce online magazine about the apparent resolution of the RxUSA lawsuit that had delayed implementaton of a couple of the pedigree provisions of the Federal PDMA (Prescription Drug Marketing Act). While Pharmaceutical Commerce did its usual great job of providing historical context, I thought it might be an appropriate topic for the RxTrace blog. But before I had time to document the history of the PDMA in my own words, Brian Daleiden beat me to it in the Supply Network Blog. So rather than writing my own version, I gladly refer you to his post. Between the Pharmaceutical Commerce article and Brian’s post, I have nothing more to say right now.
The Supply Network Blog is a fairly new publication of TraceLink, the successor to SupplyScape, my former employer. I look forward to hearing more from their blog in the future so I recently subscribed. Check it out and see what you think.
Look forward to RxTrace News-helps me to better manage key issues
Been following RxTrace ever since some of the very first postings, and it’s one of my absolutely best sources of serious and thorough analyses, on an otherwise very delicate and complicated topic. Dirk’s writings and articles comes highly recommended, and I’m always looking forward to the next posting. Many thanks from Denmark for sharing your thoughts with us all.
Easy to understand summary and discussion of complex current topics.
RxTrace is the most informative and most current source for information on tracking pharma using AIDC. Their integration of information on UDI is also rather unique. RxTrace serves the pharma stakeholders as the pharma business model evolves to include services enabled by AIDC.
RxTrace offers unique context and focus on our industry.
The first website I visit on Monday mornings is RxTrace
Government and industry between them have made the issues surrounding traceablity and pedigree of medicines confused and fluid – RxTrace is my first choice when I want to untangle the history of these issues and to understand new developments.
Rx Trace is an excellent source of timely industry insight that take complex topics and makes them easier to digest and understand
ROC IT Solutions uses RxTrace to help keep abreast with the industry view(s) on the DQSA legislation and how companies are dealing with meeting the mandates. The views and insights are valuable to our assessment of how our product roadmap reacts to best serve our clients.
RxTrace is my go-to source for information surrounding the implementation and implications of the Drug Quality and Security Act.
Thieves steal truck with $2 million in pharmaceuticals: Rx-360 lnkd.in/bNt4z9k
India's new government vows clampdown on healthcare graft lnkd.in/byBtgb6
HDMA Has Updated Their EDI ASN Guidance For DSCSA, Again wp.me/pN6hS-1t9
July 16, 2014 (9:18)
Five Years of Pharma Supply Chain AnalysisCongrats! Dick. Rxtrace has been a great source for industry information, and...
July 7, 2014 (10:18)
Five Years of Pharma Supply Chain AnalysisThanks for the informative essays. 3 suggestions. "The distribution of cer...
Adam J. Fein
July 7, 2014 (8:31)
Five Years of Pharma Supply Chain AnalysisHappy birthday, RxTrace! Dancing days are here again! Keep taking us over ...
July 6, 2014 (7:59)
DSCSA: Congress Should Have Mandated RandomizationI do not want to rattle any cages but, I do not think Randomization helps in ...
June 24, 2014 (7:10)
The FDA's Draft Guidance on Suspect Product, and Farewell ColumbusGood luck with the move, Dirk. Always an "exciting" process!